ID   LRRC7_RAT               Reviewed;        1490 AA.
AC   P70587; Q9JI42;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   18-APR-2012, sequence version 2.
DT   02-OCT-2024, entry version 161.
DE   RecName: Full=Leucine-rich repeat-containing protein 7;
DE   AltName: Full=Densin-180;
DE            Short=Densin;
DE   AltName: Full=Protein LAP1;
GN   Name=Lrrc7; Synonyms=Lap1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), PROTEIN SEQUENCE OF 582-595;
RP   715-725 AND 947-959, GLYCOSYLATION, PHOSPHORYLATION, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=8824323; DOI=10.1523/jneurosci.16-21-06839.1996;
RA   Apperson M.L., Moon I.S., Kennedy M.B.;
RT   "Characterization of densin-180, a new brain-specific synaptic protein of
RT   the O-sialoglycoprotein family.";
RL   J. Neurosci. 16:6839-6852(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 898-1490 (ISOFORMS 1; 2; 4 AND 5),
RP   DEVELOPMENTAL STAGE, MUTAGENESIS OF SER-1288 AND SER-1392, INTERACTION WITH
RP   CAMKII, PHOSPHORYLATION AT SER-1288 AND SER-1392, AND PHOSPHORYLATION AT
RP   1288 (ISOFORM 2).
RC   STRAIN=Sprague-Dawley;
RX   PubMed=10827168; DOI=10.1074/jbc.c000319200;
RA   Strack S., Robison A.J., Bass M.A., Colbran R.J.;
RT   "Association of calcium/calmodulin-dependent kinase II with developmentally
RT   regulated splice variants of the postsynaptic density protein densin-180.";
RL   J. Biol. Chem. 275:25061-25064(2000).
RN   [3]
RP   INTERACTION WITH CNKSR2 AND DLG4.
RX   PubMed=12390249; DOI=10.1046/j.1365-2443.2002.00589.x;
RA   Ohtakara K., Nishizawa M., Izawa I., Hata Y., Matsushima S., Taki W.,
RA   Inada H., Takai Y., Inagaki M.;
RT   "Densin-180, a synaptic protein, links to PSD-95 through its direct
RT   interaction with MAGUIN-1.";
RL   Genes Cells 7:1149-1160(2002).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-439; SER-441; SER-443;
RP   SER-850; THR-865; SER-947; SER-949 AND SER-1392, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Required for normal synaptic spine architecture and function.
CC       Necessary for DISC1 and GRM5 localization to postsynaptic density
CC       complexes and for both N-methyl D-aspartate receptor-dependent and
CC       metabotropic glutamate receptor-dependent long term depression (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with CNKSR2 and DLG4 (PubMed:12390249). Interacts
CC       with CTNND2/Catenin delta-2. Forms a complex with N-cadherin through
CC       CTNND2 (By similarity). Interacts with CAMK2A (PubMed:10827168).
CC       {ECO:0000250|UniProtKB:Q96NW7, ECO:0000269|PubMed:10827168,
CC       ECO:0000269|PubMed:12390249}.
CC   -!- INTERACTION:
CC       P70587; P11275: Camk2a; NbExp=2; IntAct=EBI-7798464, EBI-2640645;
CC       P70587; Q9Z1T4: Cnksr2; NbExp=3; IntAct=EBI-7798464, EBI-8548356;
CC       P70587; P31016: Dlg4; NbExp=5; IntAct=EBI-7798464, EBI-375655;
CC       P70587; P11798: Camk2a; Xeno; NbExp=2; IntAct=EBI-7798464, EBI-400384;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Postsynaptic density
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=Variant A;
CC         IsoId=P70587-1; Sequence=Displayed;
CC       Name=2; Synonyms=Variant D;
CC         IsoId=P70587-2; Sequence=VSP_010799;
CC       Name=3;
CC         IsoId=P70587-3; Sequence=VSP_010798;
CC       Name=4; Synonyms=Variant B;
CC         IsoId=P70587-4; Sequence=VSP_010800;
CC       Name=5; Synonyms=Variant C;
CC         IsoId=P70587-5; Sequence=VSP_010801;
CC   -!- TISSUE SPECIFICITY: Brain-specific. Highly concentrated at synapses.
CC       {ECO:0000269|PubMed:8824323}.
CC   -!- DEVELOPMENTAL STAGE: Expression of isoform 2 is predominant at 18 dpc,
CC       but decreased during postnatal development paralleling increased
CC       expression of isoform 4 and isoform 5. {ECO:0000269|PubMed:10827168}.
CC   -!- PTM: O-glycosylated and phosphorylated. {ECO:0000269|PubMed:8824323}.
CC   -!- MISCELLANEOUS: [Isoform 2]: This is the only isoform to have a
CC       potential transmembrane domain. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the LAP (LRR and PDZ) protein family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U66707; AAC52881.1; -; mRNA.
DR   EMBL; AF266164; AAF76466.1; -; mRNA.
DR   PIR; T31434; T31434.
DR   RefSeq; NP_476483.1; NM_057142.1.
DR   AlphaFoldDB; P70587; -.
DR   SMR; P70587; -.
DR   BioGRID; 250730; 8.
DR   CORUM; P70587; -.
DR   IntAct; P70587; 9.
DR   MINT; P70587; -.
DR   STRING; 10116.ENSRNOP00000059517; -.
DR   iPTMnet; P70587; -.
DR   PhosphoSitePlus; P70587; -.
DR   SwissPalm; P70587; -.
DR   PaxDb; 10116-ENSRNOP00000016453; -.
DR   Ensembl; ENSRNOT00000116114.1; ENSRNOP00000093706.1; ENSRNOG00000011980.9. [P70587-5]
DR   GeneID; 117284; -.
DR   KEGG; rno:117284; -.
DR   AGR; RGD:708527; -.
DR   CTD; 57554; -.
DR   RGD; 708527; Lrrc7.
DR   eggNOG; KOG0619; Eukaryota.
DR   GeneTree; ENSGT00940000156262; -.
DR   InParanoid; P70587; -.
DR   OrthoDB; 2909504at2759; -.
DR   Reactome; R-RNO-438066; Unblocking of NMDA receptors, glutamate binding and activation.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   PRO; PR:P70587; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:RGD.
DR   GO; GO:0005912; C:adherens junction; IBA:GO_Central.
DR   GO; GO:0043194; C:axon initial segment; IDA:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0030175; C:filopodium; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0014069; C:postsynaptic density; IBA:GO_Central.
DR   GO; GO:0098839; C:postsynaptic density membrane; IDA:SynGO.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0098609; P:cell-cell adhesion; IBA:GO_Central.
DR   GO; GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; IBA:GO_Central.
DR   GO; GO:0098968; P:neurotransmitter receptor transport postsynaptic membrane to endosome; IBA:GO_Central.
DR   GO; GO:0098887; P:neurotransmitter receptor transport, endosome to postsynaptic membrane; IBA:GO_Central.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IDA:RGD.
DR   GO; GO:0043113; P:receptor clustering; IBA:GO_Central.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   CDD; cd00992; PDZ_signaling; 1.
DR   Gene3D; 2.30.42.10; -; 1.
DR   Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 3.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR050614; Synaptic_Scaffolding_LAP-MAGUK.
DR   PANTHER; PTHR23119; DISCS LARGE; 1.
DR   PANTHER; PTHR23119:SF48; LEUCINE-RICH REPEAT-CONTAINING PROTEIN 7; 1.
DR   Pfam; PF13855; LRR_8; 4.
DR   Pfam; PF00595; PDZ; 1.
DR   SMART; SM00364; LRR_BAC; 10.
DR   SMART; SM00365; LRR_SD22; 5.
DR   SMART; SM00369; LRR_TYP; 11.
DR   SMART; SM00228; PDZ; 1.
DR   SUPFAM; SSF52058; L domain-like; 1.
DR   SUPFAM; SSF50156; PDZ domain-like; 1.
DR   SUPFAM; SSF52047; RNI-like; 1.
DR   PROSITE; PS51450; LRR; 15.
DR   PROSITE; PS50106; PDZ; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Direct protein sequencing; Glycoprotein;
KW   Leucine-rich repeat; Methylation; Phosphoprotein; Reference proteome;
KW   Repeat; Synapse.
FT   CHAIN           1..1490
FT                   /note="Leucine-rich repeat-containing protein 7"
FT                   /id="PRO_0000188300"
FT   REPEAT          23..44
FT                   /note="LRR 1"
FT   REPEAT          47..68
FT                   /note="LRR 2"
FT   REPEAT          70..91
FT                   /note="LRR 3"
FT   REPEAT          93..114
FT                   /note="LRR 4"
FT   REPEAT          116..137
FT                   /note="LRR 5"
FT   REPEAT          139..161
FT                   /note="LRR 6"
FT   REPEAT          162..183
FT                   /note="LRR 7"
FT   REPEAT          185..206
FT                   /note="LRR 8"
FT   REPEAT          208..229
FT                   /note="LRR 9"
FT   REPEAT          231..253
FT                   /note="LRR 10"
FT   REPEAT          254..275
FT                   /note="LRR 11"
FT   REPEAT          277..298
FT                   /note="LRR 12"
FT   REPEAT          300..321
FT                   /note="LRR 13"
FT   REPEAT          323..344
FT                   /note="LRR 14"
FT   REPEAT          346..367
FT                   /note="LRR 15"
FT   REPEAT          369..391
FT                   /note="LRR 16"
FT   REPEAT          392..413
FT                   /note="LRR 17"
FT   DOMAIN          1398..1488
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   REGION          663..709
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          775..808
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          822..899
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1194..1218
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1238..1265
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1282..1312
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        676..709
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        775..798
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        832..853
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1285..1305
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         439
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         441
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         443
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         831
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80TE7"
FT   MOD_RES         850
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         865
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         869
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80TE7"
FT   MOD_RES         947
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         949
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1118
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80TE7"
FT   MOD_RES         1149
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80TE7"
FT   MOD_RES         1233
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80TE7"
FT   MOD_RES         1288
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:10827168"
FT   MOD_RES         1392
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:10827168,
FT                   ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         1218..1241
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:8824323"
FT                   /id="VSP_010798"
FT   VAR_SEQ         1285
FT                   /note="R -> RNAAYKHNTVNLGMLPYGGISAMHAGRSMTLNLQTKSKFDLQDLPLQ
FT                   K (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10827168"
FT                   /id="VSP_010799"
FT   VAR_SEQ         1286..1325
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:10827168"
FT                   /id="VSP_010800"
FT   VAR_SEQ         1326..1399
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:10827168"
FT                   /id="VSP_010801"
FT   MUTAGEN         1288
FT                   /note="S->D: Decrease in the level of phosphorylation.
FT                   Strong decrease in the level of phosphorylation; when
FT                   associated with D-1392."
FT                   /evidence="ECO:0000269|PubMed:10827168"
FT   MUTAGEN         1392
FT                   /note="S->D: Strong decrease in the level of
FT                   phosphorylation; when associated with D-1288."
FT                   /evidence="ECO:0000269|PubMed:10827168"
FT   CONFLICT        722
FT                   /note="W -> R (in Ref. 1; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         P70587-4:1288
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1490 AA;  166879 MW;  30DC3E92EB44F2A5 CRC64;
     MTTKRKLIGR LVPCRCFRGE EEIISVLDYS HCSLQQVPKE VFNFERTLEE LYLDANQIEE
     LPKQLFNCQA LRKLSIPDND LSSLPTSIAS LVNLKELDIS KNGVQEFPEN IKCCKCLTII
     EASVNPISKL PDGFTQLLNL TQLYLNDAFL EFLPANFGRL VKLRILELRE NHLKTLPKSM
     HKLAQLERLD LGNNEFSELP EVLDQIQNLR ELWMDNNALQ VLPGSIGKLK MLVYLDMSKN
     RIETVDMDIS GCEALEDLLL SSNMLQQLPD SIGLLKKLTT LKVDDNQLTM LPNTIGNLSL
     LEEFDCSCNE LESLPPTIGY LHSLRTLAVD ENFLPELPRE IGSCKNVTVM SLRSNKLEFL
     PEEIGQMQRL RVLNLSDNRL KNLPFSFTKL KELAALWLSD NQSKALIPLQ TEAHPETKQR
     VLTNYMFPQQ PRGDEDFQSD SDSFNPTLWE EQRQQRMTVA FEFEDKKEDD ESAGKVKALS
     CQAPWDRGQR GITLQPARLS GDCCTPWARC DQQIQDMPVP QSDPQLAWGC ISGLQQERSM
     CAPLPVAAQS TTLPSLSGRQ VEINLKRYPT PYPEDLKNMV KSVQNLVGKP SHGVRVENAN
     PTANTEQTVK EKFEHKWPVA PKEITVEDSF VHPANEMRIG ELHPSLAETP LYPPKLVLLG
     KDKKESTDES EVDKTHCLNN SVSSGTYSDY SPSQASSASS NTRVKVGSLQ PTTKDAVHNS
     LWGNRIAPPF PQPLDAKPLL TQREAVPPGN LPQRPDRLPM SDAFPDNWTD GSHYDNTGFV
     SEEATGENAN NNPLLSSKAR SVPAHGRRPL IRQERIVGVP LELEQSTHRH TPETEVPPSN
     PWQNWTRTPS PFEDRTAFPS KLETTPTTSP LPERKDHMKE PTETPGPFSP GVPWEYHDPT
     PNRSLGNVFS QIHCRPDSSK GVIAISKSTE RLSPLMKDIK SNKFKKSQSI DEIDVGTYKV
     YNIPLENYAS GSDHLGSHER PDKFLGPEHG MSSMSRSQSV PMLDDEMLMY GSSKGPPQQK
     ASMTKKVYQF DQSFNPQGAV EVKAEKRIPP PFAHNSEYVQ QPGKNIAKDL VSPRAYRGYP
     PMEQMFSFSQ PSVNEDAMVN AQFASQGPRA GFLRRADSLA SSTEMAMFRR VSEPHELPPG
     DRYGRAAYRG GLEGQSSVSM TDPQFLKRNG RYEDEHPSYQ EVKAQAGSFP AKNLTQRRPL
     SARSYSTESY GASQTRPVSA RPTMAALLEK IPSDYNLGNY GDKTSDNSDI KTRPTPVKGE
     ESCGKMPADW RQQLLRHIEA RRLDRTPSQQ SNILDNGQED VSPSGQWNPY PLGRRDVPPD
     TITKKAGSHI QTLMGSQSLQ HRSREQQPYE GNINKVTIQQ FQSPLPIQIP SSQATRGPQP
     GRCLIQTKGQ RSMDGYPEQF CVRIEKNPGL GFSISGGISG QGNPFKPSDK GIFVTRVQPD
     GPASNLLQPG DKILQANGHS FVHMEHEKAV LLLKSFQNTV DLVIQRELTV
//
